Clinical Trials Logo

Thyroid Cancer Stage IV clinical trials

View clinical trials related to Thyroid Cancer Stage IV.

Filter by:
  • None
  • Page 1

NCT ID: NCT03669432 Active, not recruiting - Radiation Toxicity Clinical Trials

To Study the Impact of Radiation Treatment After Surgery in Patient With Locally Advanced Thyroid Cancer.

THYRO-RT
Start date: July 2013
Phase: N/A
Study type: Interventional

This trial deals with cancers of the thyroid gland which are advanced at the local site of thyroid. These cancers are treated with surgery and complete removal of the thyroid gland. But due to advanced nature, there is risk of re-occurrence. Radiotherapy can be used to prevent this re-occurrence. This study attempt to see the effect of radiotherapy in preventing re-occurrence and its side effects in advanced thyroid cancer.

NCT ID: NCT03159585 Completed - Solid Tumor Clinical Trials

To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor Affinity Enhancing Specific T Cell in Solid Tumors

Start date: April 14, 2017
Phase: Phase 1
Study type: Interventional

The main purpose of this trial is to investigate the safety and tolerability of TAEST16001(TCR Affinity Enhancing Specific T cell Therapy)in the multi-line treatment failed advanced solid tumors except non small cell lung cancer,including liver cancer,gastric cancer,esophageal cancer,bone and soft tissue tumors,breast cancer, bladder carcinoma,prostate carcinoma,thyroid cancer, ovarian cancer and so on. The patients must meet the two criteria: human leukocyte antigens (HLA)-A*0201+ and NY-ESO-1 positive cells≥25% by immunohistochemistry.